News & Press Releases

Life Sciences Practice Co-chair William Hicks was featured in Pharmaceutical Technology following his participation as a panelist at the OBN BioTrinity 2025 conference in London, which focused on how US uncertainty is impacting the biopharma environment.

Of Counsel Benjamin Zegarelli was quoted in 360Dx related to the future of oversight for laboratory-developed-test following a recent decision in the Eastern District of Texas that vacated the FDA's final rule on LDTs.

Member Steve Ganis was quoted in a FinOps Report article about how President Trump’s decision to classify drug cartels as foreign terrorist organizations (FTOs) has alerted anti-money laundering compliance executives at US financial institutions doing business in Latin America, particularly over AML compliance.

ESG Practice Co-chair Jennifer Rubin was quoted in a Forbes article focused on how companies should consider responding to President Trump's executive orders related to DEI.

Member Geri Haight and Associates Corbin Carter and Kevin Kim wrote an article published by the Employee Relations Law Journal about President Trump’s executive order on “gender ideology” and the different employment law considerations it raises.

Of Counsel Michelle Capezza was quoted in a Fiduciary News article discussing the important role education plays for retirement plan participants and the challenges employers face in providing such education.